Immunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-27

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

TRIGGER 1 is a previous study that evaluate the immunological risk of pregnancy in women with lung transplants in France, whose pregnancy has ended between January 1, 2012 and December 31, 2021. The primary endpoint is the occurrence of humoral rejection with a year after pregnancy.

TRIGGER 2 aims to evaluate the risk of humoral rejection if there are common antigens between the child and the lung donor. We will collect HLA typing from children to compare them to the HLA typing of the mother, the lung donor and the antibodies produced if there are.

Thus, it will help us to suggest recommendations to limit the immunological risk of pregnancy for lung transplant women.

Lung transplantation is the treatment of choice of terminal chronic respiratory failure, such as cystic fibrosis and pulmonary hypertension. Young female patient of childbearing age are concerned.

For many years, given the risk of maternal and fetal complications, pregnancies were not recommended. Studies on large cohorts of transplanted patients, particularly kidney transplanted patients, have made it possible to study the risks of maternal, obstetrical and neonatal complications.

A few studies have been published in lung transplantation on small numbers of patients. However, these publications reporting on the fate of pregnancies in cohorts of lung transplant patients do not mentioned the immunological risk, with in particular the absence of studies on the risk of humoral rejection, appearance of anti-HLA (Human Leukocyte Antigens) antibodies (Ac) and the possible appearance of anti-HLA Ac directed against the donor (donor specific antibody, DSA).

TRIGGER 1 is a previous study, whose main objective is to evaluate the immunological risk of pregnancy in women with lung transplants (mono-, bi-, or cardiopulmonary) in France, whose pregnancy has ended between January 1, 2012 and December 31, 2021. The primary endpoint is the occurrence of humoral rejection within 1 year after pregnancy.

For this study TRIGGER2, we will collect the HLA typing of the children for pregnancies that resulted in the birth of a child. Thus, we will be able to compare the HLA typing of the children with the HLA typings of the mother and the lung donor, and the antibodies produced by the mother. The primary endpoint is to evaluate the risk of humoral rejection if there are common HLA antigens between the child and the lung donor.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Fertility Study of Women Who Received Organ Transplantation

NCT03455062

Transplant Fertility

COMPLETED

Immune Monitoring and Assay Development in Organ Transplant Recipients

NCT01283295

Organ Transplantation Transplantation Immunology

RECRUITING

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

NCT05890430

Kidney Transplantation Kidney Allograft Biopsy Humoral Rejection +1 more

NOT_YET_RECRUITING

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

NCT05318196

Acute Kidney Injury Chronic Kidney Diseases Solid-organ Transplantation +3 more

RECRUITING

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

NCT07134491

Antibody Mediated Rejection After Kidney Transplantation

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Transplantation Graft Rejection Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Common HLA antigens with the lung donor

Children who have common HLA antigens with the lung donor of their mother

HLA typing of the children

Intervention Type DIAGNOSTIC_TEST

The HLA typing is made on a mouth swab of the children, that is a painless non-invasive procedure.

No common HLA antigens with the lung donor

Children without common HLA antigens with the lung donor of their mother.

HLA typing of the children

Intervention Type DIAGNOSTIC_TEST

The HLA typing is made on a mouth swab of the children, that is a painless non-invasive procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HLA typing of the children

The HLA typing is made on a mouth swab of the children, that is a painless non-invasive procedure.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children born between 01/01/2012 and 31/12/2021 of female patients over 18 years old with lung transplantation (mono, uni or cardio pulmonary) in France,
* Alive at the time of our study.
* Legal guardians' consent for oral swabbing of their child and HLA typing on this swab
* Affiliated or beneficiaries of a social security system or similar